Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation

Transplant International

Volumn 25, Issue 5, 2012, Pages

  Audard, Vincent ^a   Kamar, Nassim ^b   Sahali, Dil ^a   Cardeau Desangles, Isabelle ^b   Homs, Sébastien ^a   Remy, Philippe ^a   Aouizerate, Jessie ^a   Matignon, Marie ^a   Rostaing, Lionel ^b   Lang, Philippe ^a   Grimbert, Philippe ^a  

^a UNIVERSITÉ PARIS EST   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Focal segmental glomerulosclerosis; Recurrence; Renal transplantation; Rituximab

Indexed keywords

RITUXIMAB; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HUMAN; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHILD; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; PLASMAPHERESIS; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859728986     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01462.x     Document Type: Article

References (20)

1. Ponticelli C,. Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation. Nephrol Dial Transplant 2010; 25: 25.
2. Canaud G, Zuber J, Sberro R, et al. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study. Am J Transplant 2009; 9: 1081.
3. Ingulli E, Tejani A,. Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children-a single-center experience. Transplantation 1991; 51: 401.
4. Pardon A, Audard V, Caillard S, et al. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 2006; 21: 1053.
5. Briggs JD, Jones E,. Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 1999; 14: 564.
6. Canaud G, Martinez F, Noel LH, et al. Therapeutic approach to focal and segmental glomerulosclerosis recurrence in kidney transplant recipients. Transplant Rev (Orlando) 2010; 24: 121.
7. Vincenti F, Ghiggeri GM,. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 2005; 5: 1179.
8. Ponticelli C, Glassock RJ,. Post-transplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 2010; 5: 2363.
9. Grimbert P, Audard V, Remy P, Lang P, Sahali D,. Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant 2003; 18: 245.
10. McCarthy ET, Sharma M, Savin VJ,. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2010; 5: 2115.
11. Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 2011; 17: 952.
12. Gohh RY, Yango AF, Morrissey PE, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005; 5: 2907.
13. Haffner D, Fischer DC,. Nephrotic syndrome and rituximab: facts and perspectives. Pediatr Nephrol 2009; 24: 1433.
14. Kamar N, Faguer S, Esposito L, et al. Treatment of focal segmental glomerular sclerosis with rituximab: two case reports. Clin Nephrol 2007; 67: 250.
15. Pescovitz MD, Book BK, Sidner RA,. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006; 354: 1961.
16. Pescovitz MD,. Rituximab, an anti-cd20 monoclonal antibody: history and mechanism of action. Am J Transplant 2006; 6: 859.
17. Fornoni A, Sageshima J, Wei C, et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Science Translational Medicine 2011; 3: 85ra46.
18. Baum MA,. Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 2004; 8: 329.
19. Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996; 334: 878.
20. Shimizu M, Kitagawa K, Nishio S, et al. Successful treatment of recurrent focal segmental glomerulosclerosis after renal transplantation by lymphocytapheresis and rituximab. Transpl Int 2010; 23: e53.